Insider · CIK 0001779092
Prathyusha Duraibabu
cfoofficerdirector
Files at SGMOQ (SANGAMO THERAPEUTICS, INC), ORGO (Organogenesis Holdings Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +48,828 | $0.00 | $0 | 247,047 | Feb 20, 2026 |
| Jan 22, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -36,676 | $0.40 | $15k | 660,042 | Jan 26, 2026 |
| Nov 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -2,544 | $0.42 | $1,060 | 696,718 | Nov 26, 2025 |
| Oct 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -45,225 | $0.66 | $30k | 699,262 | Oct 24, 2025 |
| Aug 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,792 | $0.59 | $1,051 | 744,487 | Aug 26, 2025 |
| Jul 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -31,866 | $0.48 | $15k | 746,279 | Jul 24, 2025 |
| May 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,792 | $0.47 | $848 | 778,145 | May 28, 2025 |
| Apr 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -31,866 | $0.78 | $25k | 779,937 | Apr 24, 2025 |
| Feb 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,792 | $1.00 | $1,792 | 693,178 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,375 | $0.96 | $1,315 | 691,803 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Common Stock | +120,000 | $0.00 | $0 | 811,803 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Stock Option (Right to Buy)derivative | +560,000 | $0.00 | $0 | 560,000 | Feb 26, 2025 |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +49,575 | $0.00 | $0 | 198,219 | Feb 21, 2025 |
| Jan 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -129,242 | $1.15 | $149k | 694,970 | Jan 24, 2025 |
| Nov 24, 2024 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,787 | $1.88 | $3,360 | 825,583 | Nov 26, 2024 |
| Nov 25, 2024 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -1,371 | $1.94 | $2,660 | 824,212 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.